{
    "clinical_study": {
        "@rank": "72195", 
        "acronym": "ISTART", 
        "arm_group": [
            {
                "arm_group_label": "Suboxone film : OX219", 
                "arm_group_type": "Active Comparator", 
                "description": "Days 1-2 Generic buprenorphine sublingual tablet (blinded) Days 3 to 14 Suboxone Film sublingual film (open-label) Days 15-21 OX219 buprenorphine/naloxone sublingual tablet (open-label) Days 22-36 OX219 or Suboxone Film according to patient choice (open-label)"
            }, 
            {
                "arm_group_label": "OX219:Suboxone Film", 
                "arm_group_type": "Experimental", 
                "description": "Days 1-2 OX219 buprenorphine/naloxone sublingual tablet (blinded) Days 3 to 14 OX219 buprenorphine/naloxone sublingual tablet  (open-label) Days 15-21 Suboxone buprenorphine/naloxone sublingual film (open-label) Days 22-36 OX219 or Suboxone Film according to patient choice (open-label)"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess treatment efficacy and adherence of\n      OX219(Buprenorphine/Naloxone) versus SUBOXONE Film (Buprenorphine/Naloxone)and to explore\n      switching between treatments."
        }, 
        "brief_title": "Induction, STabilization, Adherence and Retention Trial (ISTART) of OX219 Buprenorphine/Naloxone", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": "Opioid Dependence, on Agonist Therapy", 
        "condition_browse": {
            "mesh_term": "Opioid-Related Disorders"
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, randomized, multicenter, parallel-group, active-controlled\n      non-inferiority study comparing treatment efficacy and adherence of the sublingual (SL)\n      tablets of OX219 versus SUBOXONE Film during the first 15 days of treatment and to explore\n      switching between OX219 and SUBOXONE Film treatments.\n\n      Approximately 787 opioid-dependent adult subjects will be screened.\n\n      Total study treatment 36 days (screening 1-7 days) , number of visits 9-10."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male/female 18 - 65 years old\n\n          2. Able to read, comprehend & sign the informed consent form\n\n          3. Meet opioid dependence criteria in DSM-IV-TR the past 12 months\n\n          4. Have a Buprenorphine-negative UDS &/or urine dipstick\n\n          5. Prepared to abstain from opioids other than the study drug & from other  addictive\n             drugs\n\n          6. Negative urine pregnancy test\n\n          7. Females of childbearing potential who use a reliable method of contraception. Females\n             of non-childbearing potential; surgically sterile or post-menopausal as defined by\n             being at least 50 years of age & having an absence of menses for at least 2 years\n\n          8. Clearance from the prescribing MD to be withdrawn from their prescribed opioids for\n             subjects receiving opioids for pain\n\n          9. Lack of clinically significant abnormalities in health assessments performed at\n             screening. Unclear cases should be approved by the medical monitor\n\n         10. At leastmild withdrawal symptoms (COWS \u2265 9)\n\n        Exclusion Criteria:\n\n          1. Pregnant, lactating or planning to be pregnant during study\n\n          2. Unwilling/unable to comply with the requirements of the protocol (e.g., pending\n             incarceration) are in a situation/condition that may interfere with participation in\n             the study\n\n          3. Prescribed treatment with generic buprenorphine monotherapy within 90 days prior\n             start of treatment\n\n          4. Daily dose of methadone over 30 mg during the past week or who received the last dose\n             of methadone less than 30 hours prior to treatment\n\n          5. Participating in other clinical studies in which medications is delivered or who have\n             used an investigational drug/device within the last 30 days\n\n          6. Allergy, sensitivity or intolerance to BUP, NAL or any related drug; history of drug\n             hypersensitivity or intolerance which, in the opinion of the investigator, would\n             compromise the safety of the subject/study\n\n          7. Staff, affiliated with, or family member of the staff directly involved with this\n             study\n\n          8. Serious untreated Axis I DSM-IV-TR psychiatric comorbidity (actively suicidal or\n             homicidal, have untreated schizophrenia)\n\n          9. Tongue/oral deformities that may affect the absorption of the drug products\n\n         10. Current/history of clinically significant medical disorder or condition which would\n             jeopardize the safety or impact the validity of the results. Unclear cases should be\n             discussed with & approved by the medical monitor\n\n         11. HIV-seropositive with a CD4+ count < 200, active AIDS defining infection in the last\n             120 days\n\n         12. Have Class III/IV congestive heart failure, symptomatic myocardial ischemia or\n             history of long QT syndrome (or an immediate family member with this condition)\n\n         13. Currently taking Class 1A antiarrhythmic medications (e.g., quinidine, procainamide,\n             & disopyramide) or Class III antiarrhythmic medications (e.g., sotalol, amiodarone, &\n             dofetilide)\n\n         14. Have uncontrolled hypertension, pulse oximetry \u2264 92%or clinically significant\n             abnormality on 12-lead ECG, including a corrected QT (QTc) interval > 450 ms\n\n         15. Severe liver disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "784", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01908842", 
            "org_study_id": "OX219-006 Protocol Amendment 4"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Suboxone film : OX219", 
                    "OX219:Suboxone Film"
                ], 
                "description": "OX219 buprenorphine/naloxone sublingual tablet", 
                "intervention_name": "OX219", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Suboxone film : OX219", 
                    "OX219:Suboxone Film"
                ], 
                "description": "Suboxone buprenorphine/naloxone sublingual film", 
                "intervention_name": "Suboxone film", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Suboxone film : OX219", 
                "description": "Buprenorphine sublingual tablets", 
                "intervention_name": "Buprenorphine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Buprenorphine", 
                "Naloxone"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Opioid", 
            "Dependence", 
            "agonist", 
            "buprenorphine", 
            "naloxone", 
            "BUP/NAL"
        ], 
        "lastchanged_date": "May 6, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Baldwin County", 
                        "country": "United States", 
                        "state": "Alabama"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston County", 
                        "country": "United States", 
                        "state": "Alabama"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maricopa", 
                        "country": "United States", 
                        "state": "Arizona"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beverly Hills", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles County", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Riverside County", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego County", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Broward County", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colombia County", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duval County", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greater Metro Orlando", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lake County", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami-Dade County", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Osceola County", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palm Beach County", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "DeKalb County", 
                        "country": "United States", 
                        "state": "Georgia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicagoland", 
                        "country": "United States", 
                        "state": "Illinois"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Johnson County", 
                        "country": "United States", 
                        "state": "Kansas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kenton County", 
                        "country": "United States", 
                        "state": "Kentucky"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caddo Parish", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore County", 
                        "country": "United States", 
                        "state": "Maryland"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bristol County", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis Metro Area", 
                        "country": "United States", 
                        "state": "Missouri"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Camden County", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warren County", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warren County", 
                        "country": "United States", 
                        "state": "Ohio"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma County", 
                        "country": "United States", 
                        "state": "Oklahoma"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland metropolitan area", 
                        "country": "United States", 
                        "state": "Oregon"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Allegheny County", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Delaware County", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia County", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston County", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas County", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake County", 
                        "country": "United States", 
                        "state": "Utah"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlottesville metropolitan area", 
                        "country": "United States", 
                        "state": "Virginia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Benton County", 
                        "country": "United States", 
                        "state": "Washington"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Induction, STabilization, Adherence and Retention Trial (ISTART) - A Randomized Non-inferiority Multicenter Study to Assess Early Treatment Efficacy of OX219 Versus SUBOXONE Film and to Explore Switching Between Treatments", 
        "overall_official": {
            "affiliation": "University of Virginia, PO Box 800623, Charlottesville, VA 22911", 
            "last_name": "Erik Gunderson", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Recording of dose administrations.", 
            "measure": "The proportion of randomized subjects retained in treatment.", 
            "safety_issue": "No", 
            "time_frame": "Day 15"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01908842"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Recording of dose switching", 
                "measure": "The proportion of subjects electing to switch from SUBOXONE Film to OX219 and vice versa", 
                "safety_issue": "No", 
                "time_frame": "Days 22 and 29"
            }, 
            {
                "description": "Scale for assessment of opioid withdrawal symptoms by clinician (or designated site staff)", 
                "measure": "Clinical Opiate Withdrawal Scale score (COWS)", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed the duration of expected average of 36 weeks."
            }, 
            {
                "description": "Scale for assessment of opioid withdrawal symptoms by subject", 
                "measure": "Subjective Opiate Withdrawal Scale score (SOWS)", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed the duration of expected average of 36 weeks."
            }, 
            {
                "description": "Scale for assessment of treatment effects of opioid cravings", 
                "measure": "Craving VAS", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed the duration of expected average of 36 weeks."
            }, 
            {
                "description": "Screen for illicit drugs/opioids/buprenorphine.", 
                "measure": "Urine drug screen (UDS) and/or urine dipstick.", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed the duration of expected average of 36 weeks."
            }, 
            {
                "description": "To assess treatment effects on illicit drug use", 
                "measure": "Self report of substance use/opioid use", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed the duration of expected average of 36 weeks."
            }, 
            {
                "description": "To assess treatment effects on addiction severity.", 
                "measure": "Addiction Severity Index - Lite (ASI-Lite)", 
                "safety_issue": "No", 
                "time_frame": "Screening and Day 36"
            }, 
            {
                "description": "Patient assessment of improvement/deterioration of opioid dependence severity.", 
                "measure": "Patient Global Impression of Improvement (PGI-I)", 
                "safety_issue": "No", 
                "time_frame": "Day 36"
            }, 
            {
                "description": "Clinician assessment of opioid dependence severity.", 
                "measure": "Clinical Global Impression of Severity (CGI-S)", 
                "safety_issue": "No", 
                "time_frame": "At screening and Day 36"
            }, 
            {
                "description": "Clinician assessment of improvement/deterioration of opioid dependence severity.", 
                "measure": "Clinical Global Impression of Improvement (CGI-I)", 
                "safety_issue": "No", 
                "time_frame": "At screening and Day 36"
            }, 
            {
                "description": "Taste, mouth feel, overall acceptability and preference of formulation.", 
                "measure": "Formulation acceptability and preference of OX219 compared to SUBOXONE Film", 
                "safety_issue": "No", 
                "time_frame": "Days 15, 22 and 29"
            }, 
            {
                "description": "Number of adverse events, blood samples (clinical chemistry and hematology), Urine pregnancy test, blood pressure, heart rate and respiration rate", 
                "measure": "Safety measurements", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed the duration of expected average of 36 weeks."
            }, 
            {
                "description": "Assess suicidal ideation/behavior", 
                "measure": "Columbia Suicidal Severity Rating Scale (C-SSRS)", 
                "safety_issue": "Yes", 
                "time_frame": "Screening and Days; 8, 15, 22, 29 and 36"
            }, 
            {
                "description": "Assessment of concomitant pain scale (numerical rating scale [NRS])", 
                "measure": "Pain Numerical rating scale (NRS)", 
                "safety_issue": "Yes", 
                "time_frame": "Screening and Days 8, 15, 22, 29, and 36"
            }, 
            {
                "description": "To assess the patient perspective on constipation symptoms", 
                "measure": "Patient Assessment of Constipation Symptoms (PAC-SYM)", 
                "safety_issue": "Yes", 
                "time_frame": "Screening and days 15 and 22"
            }, 
            {
                "description": "Patient general quality of life questionnaire", 
                "measure": "SF-36 ratings", 
                "safety_issue": "No", 
                "time_frame": "Screening and day 36"
            }, 
            {
                "description": "Patient questionnaire to evaluate the influence of opioid dependence on work capacity / other activities", 
                "measure": "Work productivity/activity impairment: Specific health problem questionnaire (WPAI:SHP)", 
                "safety_issue": "No", 
                "time_frame": "Screening and day 36"
            }
        ], 
        "source": "Orexo AB", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Orexo AB", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}